{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:04:16Z","timestamp":1790798656448,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.06.038","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:55:25Z","timestamp":1783439725000},"page":"3647-3658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Direct oral anticoagulant use and drug\u2013drug interactions in transplant recipients receiving calcineurin inhibitors"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-4713","authenticated-orcid":false,"given":"Andreas","family":"Verstraete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Dreesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Van Thillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Erard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.J.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Jacquemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Rega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Van Cleemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Verhamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vanassche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.06.038_bib1","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.06.038_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.06.038_bib3","doi-asserted-by":"crossref","first-page":"A32","DOI":"10.1093\/eurheartj\/suab153","article-title":"The value and limitations of new oral anticoagulant plasma level assessments","volume":"24","author":"Van der Linden","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jtha.2026.06.038_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/clpt.2010.106","article-title":"Quantification of apixaban\u2019s therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose","volume":"88","author":"Leil","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtha.2026.06.038_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.06.038_bib6","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/S0140-6736(14)61943-7","article-title":"Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial","volume":"385","author":"Ruff","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.06.038_bib7","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.jtha.2025.06.031","article-title":"Plasma levels measurement of the 4 direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events","volume":"23","author":"Godino","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.038_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jamaneurol.2024.2057","article-title":"Direct-acting oral anticoagulants and antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events","volume":"81","author":"Acton","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtha.2026.06.038_bib9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2024.3867","article-title":"Serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or rivaroxaban","volume":"331","author":"Ray","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.06.038_bib10","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.hlc.2019.10.011","article-title":"Atrial flutter and fibrillation following lung transplantation: incidence, associations and a suggested therapeutic algorithm","volume":"29","author":"Barnes","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jtha.2026.06.038_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.healun.2007.01.009","article-title":"High incidence of venous thromboembolic events in lung transplant recipients","volume":"26","author":"Kahan","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtha.2026.06.038_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2010.04.035","article-title":"Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation","volume":"106","author":"Dasari","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2026.06.038_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.healun.2014.09.039","article-title":"Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors","volume":"34","author":"Alvarez-Alvarez","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtha.2026.06.038_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2215\/CJN.00920805","article-title":"Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation","volume":"1","author":"Lentine","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jtha.2026.06.038_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/tri.13599","article-title":"Safety and efficacy of direct-acting oral anticoagulants versus warfarin in kidney transplant recipients: a retrospective single-center cohort study","volume":"33","author":"Bixby","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.jtha.2026.06.038_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14513","article-title":"Safety of direct oral anticoagulants in solid organ transplant recipients: a meta-analysis","volume":"36","author":"Zakko","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtha.2026.06.038_bib17","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1600-6143.2004.00539.x","article-title":"CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus","volume":"4","author":"Lemahieu","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtha.2026.06.038_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/FTD.0000000000000356","article-title":"Effect of the direct oral anticoagulants rivaroxaban and apixaban on the disposition of calcineurin inhibitors in transplant recipients","volume":"39","author":"Vanhove","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jtha.2026.06.038_bib19","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/TP.0000000000000223","article-title":"Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A","volume":"98","author":"Wannhoff","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.jtha.2026.06.038_bib20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/cts.13284","article-title":"Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients","volume":"15","author":"Mansell","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jtha.2026.06.038_bib21","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jtha.2026.06.038_bib22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/a-1450-8178","article-title":"2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants","volume":"121","author":"Douxfils","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.038_bib25","series-title":"R: A language and environment for statistical computing","year":"2024"},{"key":"10.1016\/j.jtha.2026.06.038_bib26","series-title":"RStudio: Integrated development environment for R","year":"2024"},{"key":"10.1016\/j.jtha.2026.06.038_bib27","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.jtha.2026.06.038_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v015.i02","article-title":"The R package geepack for generalized estimating equations","volume":"15","author":"Halekoh","year":"2006","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jtha.2026.06.038_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12959-025-00767-z","article-title":"Predictive thresholds of peak and trough anti-Xa levels for bleeding risk in rivaroxaban-treated nonvalvular atrial fibrillation","volume":"23","author":"Almouwannes","year":"2025","journal-title":"Thrombosis J"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:45:05Z","timestamp":1790797505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1538783626004241"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.038","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulant use and drug\u2013drug interactions in transplant recipients receiving calcineurin inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}